Week in Review: Using hydroxychloroquine, azithromycin to treat COVID-19 | Are patients afraid to seek medical attention?

Healthcare providers should use caution when considering the treatment of COVID-19 patients with hydroxychloroquine and azithromycin if the patients have cardiovascular disease.

As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.

An AI algorithm can assess echocardiograms “more rapidly and comprehensively” than experienced cardiologists, according to a new study published in Nature.

U.S. hospitals are facing numerous challenges as they work to combat the continued spread of COVID-19, according to a new government survey of more than 300 hospital administrators.

Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published in JAMA Network Open. It does, however, lead to an increased risk of hemorrhagic stroke.

Though the new coronavirus is often associated with older patients and those with preexisting conditions, it has been diagnosed in young children as well.

Smartphone cameras could play an important role in the diagnosis of AFib, according to new findings published in JAMA Network Open.

The move come as “the result of changing personal and family priorities,” according to an official statement from the ACC.